Fundraising FoxStämm
San Francisco, US · 18 known investors
Find your way into Stämm
Sign up to see every warm intro you have to Stämm
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Stämm team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Stämm is a biomanufacturing company founded in 2016 that builds the Bioprocessor, a continuous, bubble-free bioreactor using single-use 3D-printed cartridges for producing monoclonal antibodies, biosimilars, and cell and gene therapies. It serves biologics producers seeking lower costs and scalable, automated manufacturing.
Investors · 18
How we know: AIR Capital's portfolio page · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
How we know: Draper Cygnus's portfolio page · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Also in the syndicate · 11
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AMar 2022 · 2 sources
Varana Capital (lead), Cygnus Draper, Decarbonization Consortium, Dragones VC, Draper Associates, Grid Exponential, New Abundance, Serenity Traders, SOSV's IndieBio, Teramips, Trillian LLC, VistaEnergy
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Stämm do?
- Stämm is a biomanufacturing company founded in 2016 that builds the Bioprocessor, a continuous, bubble-free bioreactor using single-use 3D-printed cartridges for producing monoclonal antibodies, biosimilars, and cell and gene therapies. It serves biologics producers seeking lower costs and scalable, automated manufacturing.
- Who are Stämm's investors?
- Stämm's investors include AIR Capital, Draper Associates, Draper Cygnus, GRIDX, SOSV, Varana, Mayfield Fund.
- Where is Stämm headquartered?
- Stämm is headquartered in San Francisco, US.